ArticleDrug development research2022

Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs).

Mehdi Valipour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.